Anti-GLIS2 monoclonal antibody

Pre-made anti-GLIS2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GLIS2/GLIS2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2526-Ab-1/ GM-Tg-hg-IP2526-Ab-2Anti-Human GLIS2 monoclonal antibodyHuman
GM-Tg-rg-IP2526-Ab-1/ GM-Tg-rg-IP2526-Ab-2Anti-Rat GLIS2 monoclonal antibodyRat
GM-Tg-mg-IP2526-Ab-1/ GM-Tg-mg-IP2526-Ab-2Anti-Mouse GLIS2 monoclonal antibodyMouse
GM-Tg-cynog-IP2526-Ab-1/ GM-Tg-cynog-IP2526-Ab-2Anti-Cynomolgus/ Rhesus macaque GLIS2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2526-Ab-1/ GM-Tg-felg-IP2526-Ab-2Anti-Feline GLIS2 monoclonal antibodyFeline
GM-Tg-cang-IP2526-Ab-1/ GM-Tg-cang-IP2526-Ab-2Anti-Canine GLIS2 monoclonal antibodyCanine
GM-Tg-bovg-IP2526-Ab-1/ GM-Tg-bovg-IP2526-Ab-2Anti-Bovine GLIS2 monoclonal antibodyBovine
GM-Tg-equg-IP2526-Ab-1/ GM-Tg-equg-IP2526-Ab-2Anti-Equine GLIS2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2526-Ab-1/ GM-Tg-hg-IP2526-Ab-2; GM-Tg-rg-IP2526-Ab-1/ GM-Tg-rg-IP2526-Ab-2;
GM-Tg-mg-IP2526-Ab-1/ GM-Tg-mg-IP2526-Ab-2; GM-Tg-cynog-IP2526-Ab-1/ GM-Tg-cynog-IP2526-Ab-2;
GM-Tg-felg-IP2526-Ab-1/ GM-Tg-felg-IP2526-Ab-2; GM-Tg-cang-IP2526-Ab-1/ GM-Tg-cang-IP2526-Ab-2;
GM-Tg-bovg-IP2526-Ab-1/ GM-Tg-bovg-IP2526-Ab-2; GM-Tg-equg-IP2526-Ab-1/ GM-Tg-equg-IP2526-Ab-2
Products NameAnti-GLIS2 monoclonal antibody
Formatmab
Target NameGLIS2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GLIS2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2526-Ag-1Recombinant multi-species GLIS2/ NKL/ NPHP7 protein
    ORF Viral VectorpGMLPm004412mouse Glis2 Lentivirus plasmid
    ORF Viral VectorvGMLPm004412mouse Glis2 Lentivirus particle


    Target information

    Target IDGM-IP2526
    Target NameGLIS2
    Gene ID84662,83396,302946,708454,490028,101095217,527935,100066071
    Gene Symbol and SynonymsGli5,GLIS2,Klf16,NKL,NPHP7
    Uniprot AccessionQ9BZE0
    Uniprot Entry NameGLIS2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000126603
    Target ClassificationN/A

    The target: GLIS2, gene name: GLIS2, also named as NKL, NPHP7. This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear transcription factor with five C2H2-type zinc finger domains. The protein encoded by this gene is widely expressed at low levels in the neural tube and peripheral nervous system and likely promotes neuronal differentiation. It is abundantly expressed in the kidney and may have a role in the regulation of kidney morphogenesis. p120 regulates the expression level of this protein and induces the cleavage of this protein's C-terminal zinc finger domain. This protein also promotes the nuclear translocation of p120. Mutations in this gene cause nephronophthisis (NPHP), an autosomal recessive kidney disease characterized by tubular basement membrane disruption, interstitial lymphohistiocytic cell infiltration, and development of cysts at the corticomedullary border of the kidneys.[provided by RefSeq, Jan 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.